Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-381-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames : negative (BASF 1989, BASF 2018)
HPRT: negative (BASF 2010)
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- HPRT (hypoxanthine-guanine phosphoribosyl transferase)
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Thawed stock cultures are propagated at 37 °C in 80 cm2 plastic flasks (GREINER, 72632 Frickenhausen, Germany). About 5×105 cells are seeded into each flask with 15 mL of MEM (minimal essential medium; SEROMED, 12247 Berlin, Germany) supplemented with 10 % foetal calf serum (FCS, PAA Laboratories GmbH, 35091 Cölbe, Germany) and 1 % neomycin. The cells are subcultured twice weekly. The cell cultures are incubated at 37 °C in a 4.5 % carbon dioxide atmosphere (95.5 % air).
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- Mammalian Microsomal Fraction S9 Mix
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO; ethanol; Nutrient medium
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Evaluation criteria:
- A test item is classified as positive if it induces either a concentration-related increase of the mutant frequency or a reproducible positive response for one of the test points.
A test item producing neither a concentration-related increase of the mutant frequency nor a reproducible positive response at any of the test points is considered to be non-mutagenic in this system.
A mutagenic response is described as follows:
The test item is classified as mutagenic if it induces reproducibly with one of the concen-trations a mutation frequency that is three times higher than the spontaneous mutation fre-quency in the experiment.
The test item is classified as mutagenic if there is a reproducible concentration-related increase of the mutation frequency. Such evaluation may be considered also in the case that a threefold increase of the mutant frequency is not observed.
However, in a case by case evaluation this decision depends on the level of the corre-sponding solvent control data. If there is by chance a low spontaneous mutation rate in the range normally found (0.6 – 31.7 mutants per 106 cells), a concentration-related in-crease of the mutations within this range has to be discussed. The variability of the muta-tion rates of solvent controls within all experiments of this study is also taken into consideration. - Statistics:
- A linear regression (least squares) will be performed to assess a possible dose dependent increase of mutant frequencies using SYSTAT®11 (SYSTAT Software, Inc., 501, Canal Boulevard, Suite C, Richmond, CA 94804, USA) statistics software. The number of mutant colonies obtained for the groups treated with the test item will be compared to the solvent control groups. A trend is judged as significant whenever the p-value (probability value) is below 0.05. However, both, biological and statistical significance will be considered to-gether.
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Excessive cytotoxicity at 2 or 4µg/mL without S9 after treatment for 4h or 24h, respectively, and at 14µg/mL with S9
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix from male Wistar rats livers
- Test concentrations with justification for top dose:
- 1st Exp: 0; 33; 100; 333; 1000; 2600 and 5200 μg/plate (all strains, with and without S9 mix) SPT
2nd Exp: 0; 0.33; 1; 3.3; 10; 33 and 100 μg/plate (all strains, with and without S9 mix) SPT
3rd Exp: 0; 0.1; 0.33; 1; 3.3; 10 and 33 μg/plate (TA strains without S9 mix), 0; 0.33; 1; 3.3; 10; 33 and 100 μg/plate (TA strains with S9 mix and E.coli with and without S9 mix) PIT - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- other: 2-aminoanthracene; N-methyl-N-nitro-N-nitrosoguanidine; 4-nitro-o-phenylenediamine
- Details on test system and experimental conditions:
- Standard plate test
The experimental procedure of the standard plate test (plate incorporation method) was based on the method of Ames et al..
• Salmonella typhimurium
Test tubes containing 2-mL portions of soft agar (overlay agar), which consists of 100 mL agar (0.8% [w/v] agar + 0.6% [w/v] NaCl) and 10 mL amino acid solution (minimal amino acid solution for the determination of mutants: 0.5 mM histidine + 0.5 mM biotin) were kept in a water bath at about 42 - 45°C, and the remaining components were added in the following order:
0.1 mL test solution or vehicle (negative control)
0.1 mL fresh bacterial culture
0.5 mL S9 mix (with metabolic activation) or 0.5 mL phosphate buffer (without metabolic activation).
After mixing, the samples were poured onto Minimal glucose agar plates (Moltox Molecular Toxicology, Inc.; Boone, NC 28607; USA) within approx. 30 seconds.
After incubation at 37°C for 48 – 72 hours in the dark, the bacterial colonies (his+ revertants) were counted. The colonies were counted using the Sorcerer Image Analysis System with the software program Ames Study Manager (Perceptive Instruments Ltd., Haverhill, UK). Colonies were counted manually, if precipitation of the test substance hindered the counting using the Image Analysis System.
Escherichia coli
Test tubes containing 2-mL portions of soft agar (overlay agar), which consists of 100 mL agar (0.8% [w/v] agar + 0.6% [w/v] NaCl) and 10 mL amino acid solution (minimal amino acid solution for the determination of mutants: 0.5 mM tryptophan) were kept in a water bath at about 42 - 45°C, and the remaining components were added in the following order:
0.1 mL test solution or vehicle (negative control)
0.1 mL fresh bacterial culture
0.5 mL S9 mix (with metabolic activation) or 0.5 mL phosphate buffer (without metabolic activation)
After mixing, the samples were poured onto Minimal glucose agar plates (Moltox Molecular Toxicology, Inc.; Boone, NC 28607; USA) within approx. 30 seconds.
After incubation at 37°C for 48 – 72 hours in the dark, the bacterial colonies (trp+ revertants) were counted. The colonies were counted using the Sorcerer Image Analysis System with the software program Ames Study Manager (Perceptive Instruments Ltd., Haverhill, UK). Colonies were counted manually, if precipitation of the test substance hindered the counting using the Image Analysis System.
Preincubation Test
The experimental procedure was based on the method described by Yahagi et al. and Matsushima et al.
0.1 mL test solution or vehicle, 0.1 mL bacterial suspension and 0.5 mL S9 mix (with
metabolic activation) or phosphate buffer (without metabolic activation) were incubated at 37°C for the duration of about 20 minutes using a shaker. Subsequently, 2 mL of soft agar was added and, after mixing, the samples were poured onto the agar plates within approx. 30 seconds. After incubation at 37°C for 48 – 72 hours in the dark, the bacterial colonies were counted. The colonies were counted using the Sorcerer Image Analysis System with the software program Ames Study Manager (Perceptive Instruments Ltd., Haverhill, UK). Colonies were counted manually, if precipitation of the test substance hindered the counting using the Image Analysis
System. - Evaluation criteria:
- The test substance was considered positive in this assay if the following criteria were met:
• A dose-related and reproducible increase in the number of revertant colonies, i.e. at least doubling (bacteria strains with high spontaneous mutation rate, like TA 98, TA 100 and E.coli WP2 uvrA) or tripling (bacteria strains with low spontaneous mutation rate, like TA 1535 and TA 1537) of the spontaneous mutation rate in at least one tester strain either without S9 mix or after adding a metabolizing system. - Species / strain:
- other: TA 1535, TA 100, TA 1537, TA 98 and E.coli WP2 uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- Under the experimental conditions of this study, the test substance Tridecylamine, branched and linear (PSN 18/0023-1) is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- E. coli WP2 or S. typhimurium TA102 strain missing
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S-9 mix
- Test concentrations with justification for top dose:
- Standard plate test: 6 - 5000 µg/plate; Preincubation test: 1.25 - 50 µg/plate
- Vehicle / solvent:
- - Vehicle used: DMSO
- Justification for choice of solvent/vehicle: Copmplete solubility of test substance in DMSO - Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- without S-9: 5 µg N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) for strains TA 100 and TA 1535, 10 µg 4-nitro-o-phenylendiamine for the strain TA 98 and 100 µg 9-aminoacridine chloride monohydrate for the strain TA 1537; with S-9: 10 µg 2-aminoanthracene fo
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: standard plate test (in agar, plate incorporation) and preincubation test
DURATION
- Preincubation period: 20 minutes
- Exposure duration: 48 hours
NUMBER OF REPLICATIONS:
- Standard plate test: 2 individual experiments in triplicates
- Preincubation test: one experiment in triplicates
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth (his- background growths) - Evaluation criteria:
- A substance is regarded as positive if the following is fulfilled:
- doubling of the spontaneous mutation rate
- dose-response relationship
- reproducibility of results - Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- from 25-50 µg/plate (standard test); from 20 µg/plate (preincubation test)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- ADDITIONAL INFORMATION ON CYTOTOXICITY:
A bacteriotoxic effect was observed in the standard plate test from about 25 µg - 50 µg/plate onward (without S-9 mix) or from about 50 µg - 100 µg onward (with S-9 mix). In the preincubation test bacteriotoxicity was found using all tester strains at 20 µg/plate (without S-9 mix) or using TA 1535 at 50 µg/plate (with S-9 mix).
Referenceopen allclose all
relative | relative | mutant | relative | relative | mutant | |||||
conc. µg | S9 | cloning | cloning | colonies/ | induction | cloning | cloning | colonies/ | induction | |
per mL | mix | efficiency I | efficiency II | 10^6 cells | factor | efficiency I | efficiency II | 10^6 cells | factor | |
% | % | % | % | |||||||
Column | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
Experiment I / 4 h treatment | culture I | culture II | ||||||||
Solvent control with ethanol | - | 100.0 | 100.0 | 12.4 | 1.0 | 100.0 | 100.0 | 9.4 | 1.0 | |
Positive control with EMS | 150.0 | - | 99.8 | 53.6 | 178.2 | 14.3 | 80.8 | 88.7 | 96.5 | 10.3 |
Test item | 0.13 | - | 101.3 | 78.0 | 19.6 | 1.6 | 98.7 | 98.5 | 5.3 | 0.6 |
Test item | 0.25 | - | 105.6 | 94.2 | 13.2 | 1.1 | 95.8 | 97.6 | 16.6 | 1.8 |
Test item | 0.5 | - | 94.2 | 34.5 | 39.5 | 3.2 | 100.3 | 44.5 | 12.8 | 1.4 |
Test item | 1.0 | - | 77.1 | 37.7 | 32.2 | 2.6 | 77.4 | 41.1 | 35.6 | 3.8 |
Test item | 2.0 | - | 6.5 | 55.9 | 16.1 | 1.3 | 7.3 | 66.0 | 5.6 | 0.6 |
Test item | 3.0 | - | culture was not continued## | culture was not continued## | ||||||
Test item | 4.0 | - | culture was not continued## | culture was not continued## | ||||||
Solvent control with ethanol | 100.0 | 100.0 | 15.6 | 1.0 | 100.0 | 100.0 | 31.5 | 1.0 | ||
Positive control with DMBA | 1.1 | + | 84.3 | 97.5 | 1033.2 | 66.3 | 73.1 | 88.3 | 1083.7 | 34.4 |
Test item | 0.5 | + | 102.8 | culture was not continued# | 130.6 | culture was not continued# | ||||
Test item | 1.0 | + | 36.8 | 79.6 | 19.7 | 1.3 | 81.1 | 104.7 | 37.5 | 1.2 |
Test item | 2.0 | + | 38.0 | 85.8 | 33.1 | 2.1 | 38.2 | 98.9 | 10.8 | 0.3 |
Test item | 4.0 | + | 31.9 | 105.3 | 36.2 | 2.3 | 35.4 | 91.5 | 18.7 | 0.6 |
Test item | 8.0 | + | 23.4 | 86.4 | 30.2 | 1.9 | 34.7 | 91.3 | 17.0 | 0.5 |
Test item | 12.0 | + | 16.5 | 67.2 | 20.4 | 1.3 | 4.8 | 88.9 | 12.6 | 0.4 |
Test item | 16.0 | + | 0.0 | culture was not continued## | 0.0 | culture was not continued## | ||||
Experiment II / 24 h treatment | culture I | culture II | ||||||||
Solvent control with ethanol | - | 100.0 | 100.0 | 23.8 | 1.0 | 100.0 | 100.0 | 14.1 | 1.0 | |
Positive control with EMS | 150.0 | - | 108.5 | 99.5 | 384.0 | 16.2 | 106.6 | 108.7 | 350.6 | 24.9 |
Test item | 0.13 | - | 107.4 | culture was not continued# | 105.1 | culture was not continued# | ||||
Test item | 0.25 | - | 92.2 | 103.9 | 22.2 | 0.9 | 104.2 | 98.3 | 17.4 | 1.2 |
Test item | 0.5 | - | 102.5 | 85.8 | 25.2 | 1.1 | 115.1 | 70.0 | 19.8 | 1.4 |
Test item | 1.0 | - | 99.3 | 103.6 | 16.2 | 0.7 | 96.1 | 92.9 | 29.8 | 2.1 |
Test item | 2.0 | - | 92.9 | 97.2 | 28.0 | 1.2 | 66.6 | 96.8 | 22.0 | 1.6 |
Test item | 3.0 | - | 26.6 | 89.4 | 29.3 | 1.2 | 12.7 | 101.0 | 14.5 | 1.0 |
Test item | 4.0 | - | 0.0 | culture was not continued## | 0.0 | culture was not continued## | ||||
Experiment II / 4 h treatment | ||||||||||
Solvent control with ethanol | + | 100.0 | 100.0 | 12.4 | 1.0 | 100.0 | 100.0 | 12.0 | 1.0 | |
Positive control with DMBA | 1.1 | + | 52.1 | 90.7 | 880.1 | 70.8 | 39.7 | 73.3 | 731.9 | 60.8 |
Test item | 1.0 | + | culture was not continued# | culture was not continued# | ||||||
Test item | 2.0 | + | 84.3 | 100.7 | 16.8 | 1.4 | 41.6 | 93.3 | 33.3 | 2.8 |
Test item | 4.0 | + | 86.3 | 106.5 | 17.4 | 1.4 | 42.9 | 71.4 | 40.7 | 3.4 |
Test item | 8.0 | + | 71.6 | 96.6 | 20.8 | 1.7 | 39.1 | 100.8 | 15.7 | 1.3 |
Test item | 10.0 | + | 56.2 | 93.8 | 38.3 | 3.1 | 19.4 | 72.5 | 17.2 | 1.4 |
Test item | 12.0 | + | 42.8 | 91.4 | 14.7 | 1.2 | 17.8 | 86.3 | 36.4 | 3.0 |
Test item | 14.0 | + | 1.6 | culture was not continued## | 0.8 | culture was not continued## |
# culture was not continued since a minimum of only four analysable concentrations is required
## culture was not continued due to strong toxic effects
SOLUBILITY: No precipitation of the test substance was found with and without S9 mix.
TOXICITY: A strong bacteriotoxic effect was observed depending on the strain and test conditions from about 0.33 μg/plate onward.
MUTAGENICITY: A relevant increase in the number of his+ or trp+ revertants (factor ≥ 2: TA 100, TA 98 and E.coli WP2 uvrA or factor ≥ 3: TA 1535 and TA 1537) was not observed in the standard plate test or in the preincubation test without S9 mix or after the addition of a metabolizing system.
Standard plate test:
Dose/plate (µg) |
Without S9 mix |
With S9 mix |
||
Mean |
SD |
Mean |
SD |
|
Salmonella typhimurium TA 1535 |
||||
0 (DMSO) |
18 |
8 |
18 |
3 |
6 |
18 |
6 |
18 |
2 |
12 |
21 |
4 |
27 |
4 |
20 |
17 |
1 |
25 |
3 |
25 |
18 |
3 |
24 |
10 |
50 |
14 B |
3 |
24 |
2 |
100 |
6 B |
4 |
21 |
2 |
500 |
0 |
0 |
3 B |
1 |
2500 |
0 |
0 |
0 |
0 |
5000 |
0 |
0 |
0 |
0 |
MNNG 5.0 µg |
1130 |
140 |
||
2-AA 2.5 µg |
221 |
20 |
||
Salmonella typhimurium TA 100 |
||||
0 (DMSO) |
100 |
15 |
102 |
13 |
6 |
112 |
9 |
117 |
5 |
12 |
111 |
9 |
117 |
10 |
20 |
88 |
8 |
111 |
9 |
25 |
93 |
6 |
116 |
11 |
50 |
20 B |
8 |
105 |
16 |
100 |
1 |
2 |
82 B |
29 |
500 |
0 |
0 |
2 |
0 |
2500 |
0 |
0 |
0 |
1 |
5000 |
0 |
0 |
0 |
0 |
MNNG 5.0 µg |
1123 |
148 |
||
2-AA 2.5 µg |
1480 |
197 |
||
Salmonella typhimurium TA 1537 |
||||
0 (DMSO) |
15 |
2 |
13 |
2 |
6 |
13 |
1 |
12 |
1 |
12 |
11 |
1 |
13 |
7 |
20 |
16 |
4 |
16 |
2 |
25 |
13 B |
7 |
17 |
3 |
50 |
4 B |
1 |
13 |
3 |
100 |
2 B |
2 |
9 B |
3 |
500 |
0 |
0 |
6 |
1 |
2500 |
0 |
0 |
0 |
0 |
5000 |
0 |
0 |
0 |
0 |
AAC 100.0 µg |
327 |
29 |
||
2-AA 2.5 µg |
108 |
15 |
||
Salmonella typhimurium TA 98 |
||||
0 (DMSO) |
25 |
5 |
43 |
8 |
6 |
23 |
7 |
46 |
7 |
12 |
29 |
6 |
48 |
8 |
20 |
29 |
3 |
40 |
3 |
25 |
30 B |
3 |
36 |
4 |
50 |
B |
43 |
8 |
|
100 |
3 B |
4 |
35 B |
10 |
500 |
0 |
0 |
0 |
0 |
2500 |
0 |
0 |
0 |
0 |
5000 |
0 |
0 |
0 |
0 |
NOPD 10.0 µg |
782 |
76 |
||
2-AA 2.5 µg |
834 |
61 |
B = reduced his- background
.
Preincubation Test:
Dose/plate (µg) |
Without S9 mix |
With S9 mix |
||
Mean |
SD |
Mean |
SD |
|
Salmonella typhimurium TA 1535 |
||||
0 (DMSO) |
18 |
3 |
17 |
2 |
1.25 |
21 |
1 |
||
2.5 |
24 |
2 |
||
3 |
11 |
1 |
||
5 |
18 |
6 |
||
6 |
12 |
1 |
||
10 |
14 |
3 |
||
12 |
15 |
4 |
||
20 |
8 B |
2 |
||
25 |
15 |
3 |
||
50 |
8 B |
2 |
||
MNNG 5.0 µg |
1383 |
90 |
||
2-AA 2.5 µg |
134 |
15 |
||
Salmonella typhimurium TA 100 |
||||
0 (DMSO) |
100 |
10 |
105 |
5 |
1.25 |
134 |
21 |
||
2.5 |
123 |
5 |
||
3 |
122 |
7 |
||
5 |
119 |
14 |
||
6 |
118 |
5 |
||
10 |
115 |
23 |
||
12 |
138 |
18 |
||
20 |
78 B |
8 |
||
25 |
110 |
9 |
||
50 |
98 |
22 |
||
MNNG 5.0 µg |
1140 |
53 |
||
2-AA 2.5 µg |
513 |
86 |
||
Salmonella typhimurium TA 1537 |
||||
0 (DMSO) |
9 |
1 |
7 |
2 |
1.25 |
12 |
3 |
||
2.5 |
10 |
1 |
||
3 |
6 |
1 |
||
5 |
7 |
3 |
||
6 |
8 |
2 |
||
10 |
9 |
1 |
||
12 |
13 |
5 |
||
20 |
B |
|||
25 |
8 |
2 |
||
50 |
5 |
1 |
||
AAC 100.0 µg |
416 |
49 |
||
2-AA 2.5 µg |
95 |
5 |
||
Salmonella typhimurium TA 98 |
||||
0 (DMSO) |
20 |
2 |
29 |
1 |
1.25 |
20 |
3 |
||
2.5 |
19 |
1 |
||
3 |
32 |
3 |
||
5 |
19 |
4 |
||
6 |
29 |
2 |
||
10 |
16 |
1 |
||
12 |
33 |
6 |
||
20 |
6 B |
3 |
||
25 |
28 |
8 |
||
50 |
33 |
6 |
||
NOPD 10.0 µg |
796 |
105 |
||
2-AA 2.5 µg |
1093 |
155 |
B = reduced his- background
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
MNT negative (BASF 2002)
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- other: Crl:NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland GmbH
- Age at study initiation: 5 - 8 weeks
- Weight at study initiation: mean ca. 28 g
- Housing: single housing in Makrolon cages, type Ml
- Diet: Kliba Haltungsdiät (Provimi Kliba SA, Kaiseraugst, Switzerland) ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 / 12 - Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle: olive oil Ph.Eur./DAB
- Justification for choice of vehicle: Due to the insolubility of the test substance in water, olive oil was selected as the vehicle, which had been demonstrated to be suitable in the in vivo micronucleus test and for which historical data are available.
- Concentration of test material in vehicle: 2, 4 or 6 g/100 ml - Details on exposure:
- APPLIED VOLUME:
10 ml/kg bw - Duration of treatment / exposure:
- - Sacrifice intervals: 24 hours (vehicle control, 200, 400 and 600 mg/kg TS and positive controls) and 48 hours (vehicle control and 600 mg/kg TS)
- Frequency of treatment:
- single oral administration
- Remarks:
- Doses / Concentrations:
200, 400, 600 mg/kg
Basis: - No. of animals per sex per dose:
- 5 males
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide (CPP) and Vincristine Sulphate (VCR)
- Justification for choice of positive control: The stability of CPP and VCR is well-defined under the selected conditions, since both positive control articles are well-defined clastogens and aneugens, respectively.
- Route of administration: oral by gavage
- Doses / concentrations: CPP: 20 mg/kg bw, VCR: 0.15 mg/kg bw - Tissues and cell types examined:
- Erythrocytes were prepared from femur bone marrow and stained for microscopic evaluation. 2000 polychromatic erythrocytes per animal were evaluated and the following parameters were recorded: number of polychromatic and normochromatic erythrocytes, each with and without micronuclei; number of small and large micronuclei. The ratio of polychromatic to normochromatic erythrocytes was calculated from the recorded data.
- Evaluation criteria:
- The test is considered valid and acceptable if the slides allow to evaluate sufficient cells, i.e. >/= 2000 polychromatic cells; and if the proportion of micronuclei in negative controls was within the range of historical control data; and if the two positive control chemicals induced an increase within the range of historical positive control data. The test chemical is considered positive if a dose-related and significant increase in the number of micronucleated polychromatic erythrocytes is noted at any of the intervals; and if the proportion of micronuclei bearing cells exceeded both the concurrent and the historical negative control range. If these criteria are not met the test chemical is considered negative in this test.
- Statistics:
- The Wilcoxon test for the hypothesis of equal medians was used to compare dose groups with vehicle groups.
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- CLINICAL SIGNS
In the pretest, mortalities were noted down to 1000 mg/kg body weight. 800 mg/kg were survived by both male and female mice, but caused tremor, squatting posture, and poor general state. In the main test, 5/10 animals died at 800 mg/kg within 48 h. The highest dose was therefore lowered to 600 mg/kg. No clinical signs were noted at 200 mg/kg. Transient squatting posture was seen in animals receiving 400 mg/kg 1 h after dosing. At 600 mg/kg, squatting posture was seen in all animals on the first and second day after treatment as was tremor. Poor general state was seen 1 h after treatment in all high dose animals.
ERYTHROCYTES
In the negative control groups, polychromatic erythrocytes containing micronuclei amounted to 1.0 ‰ after 24 h and 0.7 ‰ after 48 h. Cyclophosphamide led to exclusively small micronuclei, incidence was 14.8 ‰. Proportion following vincristine treatment was 99.6 ‰, with an expected amount of large micronuclei, i.e. 27.8 ‰. Effects of both positive control chemicals were statistically significant on the P<0.01 level.
Single doses of Tridecylamine led to 0.8 ‰ (200 mg/kg), 0.9 ‰ (400 mg/kg). The high dose led to 2.2 ‰ (24 h) and 1.1 ‰ (48 h). This was within the range of historical control data.
The number of normochromatic erythrocytes containing micronuclei was unchanged in the various dose groups. The number of normochromatic or polychromatic erythrocytes containing small micronuclei (d < D/4) or large micronuclei (d > D/4) did not deviate from the vehicle control value at any of the sacrifice intervals and was within the historical control range. A slight inhibition of erythropoiesis was seen at 600 mg/kg, as determined from the ratio of polychromatic to normochromatic erythrocytes.
Reference
Ratio polychromatic (PCE) and normochromatic (NCE) erythrocytes:
Dose (mg/kg bw) |
Interval (h) |
Ratio PCE/NCE |
0 |
24 |
3.11 |
0 |
48 |
2.82 |
200 |
24 |
3.36 |
400 |
24 |
3.03 |
600 |
24 |
2.16 |
600 |
48 |
2.13 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
In vitro:
TDA was tested negative in the Ames test with and without metabolic activation, both in the standard plate test and in the preincubation test (BASF AG, 1989). The study was conducted according to OECD TG 471. The substance was tested in the range 6 – 5000 μg/plate in the standard test and 1.25 – 50 μg/plate in the Preincubation test using the S. typhimurium test strains TA1535, TA100, TA1537, and TA98. Bacteriotoxic effects were seen in the standard plate test from about 25 – 50 μg/plate without metabolic activation and from 50 – 100 μg/plate with metabolic activation. In the preincubation test cytotoxicity was seen in all test strains at 20 μg/plate without metabolic, or with metabolic activation at 50 μg/plate only in TA 1535.
In addition, an Ames-Tests with Tridecylamine, branched and linear was conducted in 2018 to evaluate the toxicological properties of a new batch of TDA and to include all 5 required strains.
The test substance Tridecylamine, branched and linear (PSN 18/0023 -1) was tested for ist mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli, in a reverse mutation assay. Strains tested TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA at a dose range of 0.33 μg - 5200 μg/plate (SPT) and 0.1 μg - 100 μg/plate (PIT). Standard plate test (SPT) and preincubation test (PIT) both with and without metabolic activation (liver S9 mix from induced rats). No precipitation of the test substance was found with and without S9 mix. A strong bacteriotoxic effect was observed depending on the strain and test conditions from about 0.33 μg/plate onward. A relevant increase in the number of his+or trp+revertants (factor≥2: TA 100, TA 98 and E.coli WP2 uvrA or factor≥3: TA 1535 and TA 1537) was not observed in the standard plate test or in the preincubation test without S9 mix or after the addition of a metabolizing system. Under the experimental conditions of this study, the test substance Tridecylamine, branched and linear (PSN 18/0023-1) is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay in the absence and the presence of metabolic activation (BASF SE, 2018).
Gene mutation in mammalian cells was examined in an HPRT assay (BASF 2010). Chinese hamster V79 cells were exposed to the registered substance in two independent experiments, using two parallel cultures each. The first main experiment was performed with and without liver microsomal activation and a
treatment period of 4 hours. The second experiment was performed with a treatment time of 4 hours with and 24 hours without metabolic activation. The highest applied concentrations of 4.0 μg/mL (4 hours treatment without S9 mix) in experiment I, 16.0 μg/mL (4 hours treatment with S9 mix) in experiment I, 4.0 μg/mL (24 hours treatment without S9 mix) in experiment II and 14 μg/mL (4 hours treatment with S9 mix) in experiment II were limited by test item induced cytotoxicity. No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments. Vehicle and appropriate positive controls yielded the expected results.
In vivo:
TDA was tested negative in a Mouse Micronucleus test that was performed in accordance with OECD TG 474 (BASF AG, 2002). The mice received single doses of 200, 400, and 600 mg TDA dissolved in olive oil/kg bw by oral gavage which caused clinical signs of toxicity at the mid- and the high-dose level. Transient squatting posture was seen in animals receiving 400 mg/kg bw at 1 h after dosing. At 600 mg/kg bw, squatting posture and tremor were seen in all animals on the first and second day after treatment. Poor general state was seen at 1 h after treatment in all high dose animals. In the main test, 5/10 animals died at 800 mg/kg within 48 h. The highest dose was therefore lowered to 600 mg/kg bw in the course of the study.
The evaluation of 2000 polychromatic erythrocytes 24 and 48 hours after dosing revealed that the proportion of polychromatic erythrocytes containing micronuclei was 0.8, 0.9, and 2.2 ‰ in the groups at 200, 400, and 600 mg/kg bw, respectively, after 24 hours, and 1.1 ‰ after 48 hours in animals receiving the high dose. This was within the range of the historical control data for this vehicle (mean ± SD: 2.0±0.6 ‰; n=56). At the high dose, TDA slightly inhibited erythropoiesis, showing that the test material had reached the target. The positive control substances, cyclophosphamide and vincristine, gave significantly positive effects on the p< 0.01 level as expected. Overall, there was no indication of a clastogenic or aneugenic activity.
Justification for classification or non-classification
TDA was not mutagenic bacteria and mammalian cells in vitro. The substance did not induce micronuclei in vivo. Consequently, it does not have to be classified for mutagenicity according to Regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.